Application 019437

Type
NDA
Sponsor
ICU MEDICAL INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
004AMINOSYN II 10% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDEINJECTABLE;INJECTION10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLNoNo
005AMINOSYN II 8.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDEINJECTABLE;INJECTION8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLNoNo
006AMINOSYN II 7% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDEINJECTABLE;INJECTION7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLNoNo
007AMINOSYN II 3.5% MAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATEINJECTABLE;INJECTION3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLNoNo
008AMINOSYN II 8.5% W/ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASICINJECTABLE;INJECTION8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N019437-004AMINOSYN II 10% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03
N019437-005AMINOSYN II 8.5% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03
N019437-006AMINOSYN II 7% W/ ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03
N019437-007AMINOSYN II 3.5% MAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-03
N019437-008AMINOSYN II 8.5% W/ELECTROLYTESAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 5 of 6 · 225 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2024-02-18 07:12 UTC2024-02N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-031c564ffb4f44…
2024-02-18 07:12 UTC2024-02N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-031c564ffb4f44…
2024-02-18 07:12 UTC2024-02N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-031c564ffb4f44…
2024-02-18 07:12 UTC2024-02N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-031c564ffb4f44…
2024-02-18 07:12 UTC2024-02N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-251c564ffb4f44…
2023-12-20 04:57 UTC2023-12N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-03ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-25ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-03a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-25a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-039b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-039b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-039b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-039b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-259b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-03a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-25a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-033f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-033f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-033f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-033f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-253f0d92c62455…
2023-05-13 08:27 UTC2023-05N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03053a50430f4f…
2023-05-13 08:27 UTC2023-05N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03053a50430f4f…
2023-05-13 08:27 UTC2023-05N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-03053a50430f4f…
2023-05-13 08:27 UTC2023-05N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-03053a50430f4f…
2023-05-13 08:27 UTC2023-05N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-25053a50430f4f…
2023-01-26 05:58 UTC2023-01N019437-004AMINOSYN II 10% W/ ELECTROLYTES10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-033bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N019437-005AMINOSYN II 8.5% W/ ELECTROLYTES8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-033bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N019437-006AMINOSYN II 7% W/ ELECTROLYTES7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100MLINJECTABLE / INJECTION1986-04-033bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N019437-007AMINOSYN II 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100MLINJECTABLE / INJECTION1986-04-033bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N019437-008AMINOSYN II 8.5% W/ELECTROLYTES8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100MLINJECTABLE / INJECTION2002-10-253bdfa0b2c4d7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 1 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0409-4171Aminosyn II with ElectrolytesISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, ALANINE, ARGIHospira, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
17404SUPPL2004-05-27
17403SUPPL2003-07-06